Figure 5.
Comprehensive flow cytometry data from human adipose (AD)-MSC cell lines (A1,A2) subjected to PT supplemented DM semi-batch culture at four-(A1–4D,A2–4D) and seven-(A1–7D,A2–7D)day time points (n = 3 per cell-line/treatment/timepoint) and analysis of MYH II expression compared to cell lines cultured in CCM (control). The treatments without primary antibody addition are considered secondary controls. The differences between the treatments were not statistically significant. Each data point was obtained based on the measurement of 20,000 events in FACS CANTO II.